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Leptospirosis is a prevalent infectious disease affecting both
humans and animals worldwide. This infection is associated
with occupational or recreational exposure to animals as well
as contact with leptospires, particularly in flood-prone areas.
Multiple organ dysfunctions may be associated with acute
severe leptospirosis. A triad presentation of fever, jaundice,
and acute renal failure in patients with acute multiple organ
dysfunction should alert physicians to possible leptospirosis.
Penicillin is effective and can rescue multiple organ failure if
administered early. Renal involvement is common in
leptospirosis characterized by tubulo-interstitial nephritis,
and tubular dysfunction. Leptospira outer membrane
proteins (OMPs) may elicit tubular injury and inflammation
through Toll-like receptors (TLRs)-dependent pathway
followed by activation of nuclear transcription factor kappa B
and mitogen-activated protein kinases and a differential
induction of chemokines and cytokines relevant to tubular
inflammation. Leptospira OMP may also induce activation of
the transforming growth factor-b/Smad-associated fibrosis
pathway leading to accumulation of extracellular matrix.
Thus, leptospirosis renal disease is a model for understanding
the pathogenesis and initiation of pathogen-induced
tubulo-interstitial nephritis and fibrosis. In particular,
TLRs may be important mediators.
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Leptospirosis is the most widespread zoonosis, particularly in
warm and humid regions.1 The disease is caused by the
spirochetal infection, leptospira-infected animals shedding
urine into water or soil to infect human via skin or
gastrointestinal routes. Occupational exposures, recreational
activity, flooding, and household environments in close
contacts with animals increase the risk of infection in
humans.
A wide range of clinical manifestations occurs in humans
acquiring pathogenic leptospira from animals. The clinical
syndromes of leptospirosis vary from subclinical infection,
self-limited anicteric febrile illness to severe and potentially
fatal disease.1,2 As a worldwide infection, endemic and
epidemic spread of leptospirosis has caused morbidity and
mortality, which suggest that leptospirosis is a re-emerging
infectious disease throughout the world especially in develop-
ing areas.3
Interestingly, the kidney is the main target of leptospira in
both acute and chronic infection. Acute kidney injury as a
result of tubulointerstitial nephritis is an early and primary
manifestation of systemic leptospirosis.4 In chronic infection,
leptospira may colonize and persist in the proximal tubule
leading to carrier state and progress to chronic tubulointer-
stitial nephritis and fibrosis.1 Early in vitro observation has
revealed that pathogenic leptospira, but not non-pathogenic
leptospira, attached to cultured renal epithelial cells soon
after adding to culture cells.5 These observations suggest that
leptospira is a kidney-prone micro-organism, elicits tubulo-
interstitial nephritis and progressing to fibrosis; it is therefore
an appropriate model for studying the pathogenesis of
micro-organism-related kidney diseases. The pathogenic
mechanism has been clarified in recent years by in vitro
and in vivo models employed to dissect the initiating role of
leptospirosis renal diseases. This mini-review summarizes the
recent advances in understanding the initiation of renal
injury and inflammation in leptospirosis and the role of
innate immunity Toll-like receptors (TLRs) that could be a
common initiation mechanism of kidney diseases.
CLINICAL MANIFESTATION OF LEPTOSPIROSIS
Typical clinical manifestations of leptospirosis fall into four
categories: (i) mild influenza-like illness; (ii) Weil’s syndrome
characterized by jaundice, renal failure, hemorrhage, and
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myocarditis with arrhythmias; (iii) meningitis/meningoence-
phalitis; and (iv) pulmonary hemorrhage with respiratory
failure.6 In 5–10% of leptospirosis cases, multiple organ
damage is induced with characteristic kidney, liver, and lung
lesions. Weil’s syndrome, the most severe form of the
infection, is characterized by febrile illness, hemorrhagic
tendency, hepatic dysfunction, and acute renal failure, and
may lead to fatality at a short time. A triad presentation in
acute ill patients with fever, jaundice, and acute renal failure
should alert the clinician of possible leptospirosis.4,7 The
presence of oliguria is an independent risk factor for
mortality and non-survivors have an increased incidence of
cardiac arrhythmia, dyspnea, and pulmonary rales.8
DIAGNOSTIC METHOD FOR LEPTOSPIROSIS
The diagnosis of leptospirosis depends mainly on serologic
methods (microscopic agglutination test) to detect antibody
to leptospira, polymerase chain reaction to detect leptospira
DNA and culturing the micro-organism.9 The microscopic
agglutination test is the most widely used diagnostic method
because of the relative difficulty in culturing leptospira.
Recently, immunoglobulin M assay has been used for rapid
screening of acute leptospirosis.10
CLINICAL DISTINCTION OF LEPTOSPIROSIS FROM MULTIPLE
ORGAN DYSFUNCTION PATIENTS
Systemic infections from microorganisms other than leptos-
pira may also induce multiple organ dysfunctions and
confuse the clinical diagnosis of leptospirosis. A case–control
study was conducted for differential diagnosis of leptospirosis
and other infections.11 Twenty-two confirmed and twenty-
one excluded cases of leptospirosis were identified from 169
suspected cases. The most common presentations of
leptospirosis group were fever (95.5%, 21/22), acute renal
failure (86.4%, 19/22), myalgia (72.7%, 16/22), and jaundice
(63.6%, 14/22). Incidence of hemorrhagic diathesis, myalgia,
enlarged kidneys, sterile pyuria, and thrombocytopenia were
increased in the confirmed leptospirosis group in comparison
with those for the excluded cases. Penicillin treatment was
effective in the confirmed leptospirosis group and resulted in
low fatality rate of 4.5% (1/22). This case–control study
provides characteristics of leptospirosis that could be
identified for differentiation from other infectious diseases.
Thus, prompt recognition of leptospirosis by characteristic
presentations and timely antibiotics treatment can reduce the
mortality rate for infected patients, even in cases with severe
multiple organ damage.
ACUTE RENAL FAILURE AND THROMBOCYTOPENIA
According to a previous study,12 thrombocytopenia is closely
correlated with occurrence of acute renal failure and is
described in all anicteric cases with acute renal failure.13
Thrombocytopenia in association with acute renal failure
appears independently of disseminated intravascular coagu-
lation and may be concurrent with severe endotoxin injury of
leptospirosis.14 In a series study of 12 patients with acute
renal failure, thrombocytopenia occurred in eight patients
and, notably, in four patients requiring hemodialysis.14
Therefore, thrombocytopenia may be an associated sign of
acute leptospirosis renal disease.
ACUTE TUBULOINTERSTITIAL NEPHRITIS AND TUBULAR
TRANSPORT DYSFUNCTION
Renal involvement is common in leptospirosis. Renal
dysfunction ranges from prerenal azotemia to severe acute
renal failure requiring dialysis therapy. The incidence of acute
renal failure varies widely reaching as high as 40–60% in
severe leptospirosis.15 Hypokalemia occurs frequently due to
tubular dysfunction and tubulo-interstitial nephritis is the
principle renal lesion to cause renal failure. In addition,
severe hypotension is an important sign for subsequent
development of renal and pulmonary complications.16 Thus,
hemodynamic alterations, immune response, and direct
nephrotoxicity are involved in the development of renal
lesions.
Tubulointerstitial nephritis with interstitial edema and
mononuclear cellular infiltration are main pathologic find-
ings.17,18 Glomerular changes are usually unremarkable.
Tubular cell necrosis and vasculitis are observed in the acute
phase of the disease. Previous reports have shown that the
main factors in the pathogenesis of the renal lesions are
related to the presence of micro-organisms elicited by their
migration, elaboration of their virulent toxins, and the
induction of immune response.19 In the infected host,
pathogenic leptospires can disseminate hematogenously and
invade kidneys, which represent one of the most frequently
affected organs. Through the bacterial invasion and toxicity
of outer membrane components with generation of cyto-
kines, chemokines, and cellular infiltration lead to the
development of tubulointerstitial nephritis.1,4,20 Clinically,
non-oligouric acute renal failure, hypokalemia, and sodium
wasting occur frequently in leptospirosis. The pathophysio-
logy of tubular dysfunction in leptospirosis involves proximal
tubular dysfunction, augmenting distal sodium delivery, and,
consequently, potassium excretion by the intact distal
tubule.21
In Leptospira santarosai serovar Shermani infected patients
presenting with polyuria and hypokalemia, detailed in vivo
tubular clearance tests were performed and identified a
defective Naþ -Kþ -Cl co-transporter (NKCC2) and poor
response to furosemide infusion due to tubular dysfunc-
tion.22 An in vitro study using medullary thick ascending
limb-cultured cells derived from normal mice, demonstrated
downregulation of NKCC2 mRNA expression and inhibition
of NKCC2 co-transporter activity in medullary thick
ascending limb cells by Leptospira santarosai serovar Sher-
mani outer membrane protein (OMP) extract. Effective
treatment of leptospirosis reverses the tubular dysfunction.23
These changes may account for the observed electrolyte
disorders induced by Leptospira santarosai serovar Sherma-
ni.24 However, the changes may not be a general pheno-
menon, as other serovars such as Leptospira interrogans
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serovar Bratislava did not affect function of NKCC224 and the
levels of NKCC2 may be increased in the hamster model
induced by Leptospira pomona serovar Pomona.25
CHARACTERISTIC SONOGRAPHIC FINDINGS
Characteristic early renal sonographic findings in acute
leptospirosis are swollen kidneys and relatively normal
parenchymal echogenecity indicating tubulointerstitial
edema.4 The enlarged kidney returns to a normal size after
effective treatment of the acute leptospirosis.11
REDUCED MORTALITY WITH PENICILLIN TREATMENT
Clinical studies have demonstrated the effectiveness of early
antibiotic treatment for treating leptospirosis.26 Intravenous
penicillin is recommended in severe cases, but oral antibiotics
such as doxycycline, amoxycillin, ampicillin, or erythromycin
are effective in less severe cases. Third-generation cephalos-
porins such as ceftriaxone also appear to be effective.27,28
Jarisch–Herxheimer reactions may occur following effective
treatment. Although leptospira has shown sensitivity to a
wide range of antibiotics in in vitro and animal experiments,
clinical experience with the newer antibiotics is limited. Early
intravenous administration of penicillin has proven effective
in leptospirosis patients. In a series, serum creatinine levels of
confirmed cases improved in a mean of 2.772.2 days after
intravenous penicillin administration.11 Therefore, treatment
with effective antibiotics should be initiated as soon as
leptospirosis is suspected pending confirmation.
UNDERSTANDING THE PATHOGENESIS OF LEPTOSPIROSIS
RENAL DISEASE
The mechanism of leptospirosis renal dysfunction has not
been fully studied and elucidated despite being an important
cause of acute renal failure worldwide. Early observational
studies have indicated that the leptospira spread through
hematogenous route to the kidney, circulate to glomeruli,
peritubular capillary and migrate to interstitium, renal
tubule, and finally remain in the proximal tubular lumen.20
Similar renal injuries have been reproduced in animal models
of leptospirosis. The kidneys of guinea pigs with leptospirosis
revealed tubular cell injury, interstitial nephritis and
associated microvascular injury, particularly at the cortico-
medullary junction.29,30 Ultrastructural study of the kidney
after inoculation of leptospira in mice demonstrated the
entry route of leptospira is by penetration of the capillary
lumen at day 2 followed by entrance into interstitial tissue
elaborating edema and cellular infiltration at days 4–8.
Leptospira can be found in the proximal tubular cells at
day 10, and in the tubular lumen at day 14.31 Leptospiral
antigens are found in the proximal tubule cells, macrophages,
and in the form of large extracellular clumps in the
interstitium.32 A leptospiral glycolipoprotein, a component
of leptospiral endotoxin, has been found expressed in
infected renal tubules and vascular lumen of the interstitium,
which parallels tubulo-interstitial nephritic changes.30 The
association of leptospira with membrane-bound protein
droplets in proximal tubules may thus be important in the
induction of tubulo-interstitial nephritis and of chronic
carrier state in rat leptospirosis where diffuse interstitial
nephritis and fibrosis may be initiated.33
LEPTOSPIRA OMP AND ENDOTOXINS
The outer membrane of spirochete and gram-negative
bacteria serves as a permeability barrier. In leptospira, the
outer membrane contains antigenic and virulent components
including lipoprotein, lipopolysaccharide, and peptidoglycan.
Clinical and pathological observations suggest that outer
membrane components may play a role in the pathogenesis
of leptospirosis. Leptospiral endotoxins, located on the outer
membrane, appear to be the major antigens affecting
immunity to leptospira and might be responsible for renal
dysfunction.34 Owing to their location on the cell surface,
leptospira OMPs are likely to be relevant to host–pathogen
interactions determining virulence and pathogenesis. Im-
muno-electron microscopy has revealed leptospiral antigen
adjacent to cell membrane of hepatocyte, kidney tubular cells
and endothelial cells of the interstitial capillary in animal
study.35 A disturbed tubular function and inflammation,
therefore, may be elicited by the leptospiral OMP compo-
nents. Several OMP of pathogenic leptospira have been
identified and localized to proximal tubules and the
interstitium in infected animals.36,37 To elucidate the
mechanism of tubulo-interstitial injury caused by leptospira
infection, the effect of the leptospira OMP extract on
cultured mouse renal tubular epithelial cells on the expres-
sion of a variety of genes related to tubular injury and
inflammation was evaluated.38 The leptospira OMP activates
nuclear transcription factor kappa B (NF-kB), activator
protein-1, and downstream genes expressed in medullary
thick ascending limb cells.38 The OMP is heat labile and an
antiserum raised against leptospira may prevent these effects.
Further identification of LipL32, a major pathogenic outer
membrane lipoprotein, induces tubulointerstitial nephritis-
mediated gene expression in mouse proximal tubule cells.39
Previous studies have demonstrated that LipL32 expresses
during cultivation and mammalian infection. Immuno-
histochemistry has confirmed intense LipL32 reactivity with
leptospira infecting proximal tubules of hamster kidneys and
as a prominent immunogen during human leptospirosis.40
LipL32 is also a hemolysin, which causes hemolysis of
erythrocyte during leptospira infection.41,42 The sequence
and expression of LipL32 is highly conserved among
pathogenic leptospira species indicating that LipL32 may be
important in the pathogenesis, diagnosis, and prevention of
leptospirosis.
In the kidney, LipL32 directly affects proximal tubular cells
by substantially increasing gene and protein expression of
proinflammatory cytokines such as inducible nitric oxide
(iNOS), monocyte chemoattractant protein-1 (CCL2/MCP-1),
regulated upon activation, normal T-cell expressed and
secreted (RANTES), and tumor necrosis factor (TNF-a).
Increased nitric oxide expression by medullary thick ascend-
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ing limb cell suggests that hemodynamic adaptation of the
protective vasodilatation mechanism is being elicited. How-
ever, an injurious condition may be induced by production of
peroxynitrite and free oxygen radicals. The chemokine CCL2/
MCP-1 is involved in interstitial nephritis, one of the most
important initiating factors in monocytic cells infiltration in
interstitial nephritis. The increase of CCL2/MCP-1 may
indicate the role of OMP in tubulo-interstitial nephritis. The
cytokine TNF-a, an immune and inflammatory cytokine that
mediates enodotoxemia, may affect inflammation in leptos-
pirosis renal disease. These findings indicate the importance
of LipL32 in the pathogenesis of leptospirosis renal diseases.
Therefore, identification of novel OMP of the leptospira shall
continue as a primary focus for future study for the
pathogenesis, diagnosis, and vaccine development.
Conversely, OMP extract from avirulent non-pathogenic
Leptospira biflexa serovar Patoc did not induce significant
changes in gene expression. These findings are compatible
with the notion that saprophytic avirulent leptospira does
not induce clinical manifestation as demonstrated by lacking
characteristic leptospira endotoxin, a different pattern of
outer membrane antigens expression by immunoblotting
assay,43 and readily phagocytosed by human monocyte and
polymorphonuclear cells.44,45
TLR PATHWAYS ARE INVOLVED IN LEPTOSPIROSIS
TUBULO-INTERSTITIAL NEPHRITIS
TLRs are proteins that recognize specific molecular patterns
of pathogens representing the first line of defence in innate
immunity. These receptors interact with a variety of
exogenous and endogenous ligands and initiate a cascade of
signaling events leading to the production of numerous
cytokines and effector molecules. The effect of TLRs was
evaluated to determine whether TLRs could mediate the
inflammatory response induced by leptospiral OMP in renal
proximal tubule cells.
In the cultured renal proximal tubule cells, Leptospira
santarosai serovar Shermani OMPs and LipL32 induced a
significantly increased expression of TLR2 but not TLR4. The
increased expression of iNOS and CCL2/MCP-1 mRNA
expressions could be suppressed by an anti-TLR2 antibody,
but not by an anti-TLR4 antibody. Furthermore, leptospiral
OMP stimulated both CCL2/MCP-1 mRNA and secreted
protein in transfected human embryonic kidney 293 cells
with a TLR2-expressing plasmid but had no effect on cells
with a TLR4-expressing plasmid. These findings signify that
the stimulation of iNOS and CCL2/MCP-1 caused by
pathogenic leptospiral OMP, in particular LipL32, in
proximal tubule cells requires TLR2 for the early inflamma-
tory response.46
DIFFERENTIAL INDUCTION OF TLR2-ASSOCIATED SIGNALS
IN PROXIMAL TUBULE CELLS
Further study of the TLRs signaling pathway showed that
Leptospira santarosai serovar Shermani OMP stimulated the
secretion of pro-inflammatory mediators in renal tubule
epithelial cells in a differential induction manner dependent
on mitogen-activated protein kinase (MAPK) and NF-kB
associated pathways. First of all, the leptospira OMP
upregulated TLR2 mRNA expression in proximal tubule cells
in a time- and dose-dependent effect. Further, leptospira
OMP stimulated the activation of extracellular signal-
regulated kinases (ERK1/2), c-Jun N-terminal kinases
(JNKs), and p38 MAPK, initiated the NF-kB, activator
protein-1 and enhanced the secretion of CCL2/MCP-1 and
CXCL2/MIP-2. The OMP enhanced the secretion of CCL2/
MCP-1 and CXCL8/interleukin-8 (CXCL8/IL-8) in TLR-
defective human embryonic kidney 293 cells only when
transfected with a TLR2 expressing plasmid. Secretions of
CCL2/MCP-1 and CXCL2/MIP-2 stimulated by OMP were
significantly reduced by incubating proximal tubule cells with
p38 MAPK inhibitor. Finally, a neutralizing anti-mouse TLR2
antibody hindered the phosphorylation of p38 and OMP-
stimulated secretion of CCL2/MCP-1 and CXCL2/MIP-2.
These findings demonstrate that activation of p38 MAPK and
release of chemokines by OMP are mediated by TLR2 in renal
proximal tubule cells.47
Cytokine protein array analysis has further revealed
significant upregulation of neutrophil-chemoattractant ker-
atinocyte-derived chemokine (CXCL1/KC) at nanogram
range of OMP stimulation in cultured murine proximal
tubule cells. The OMP stimulated early secretion of human
growth-related oncogene-a, a functional homolog to murine
KC, in TLR-defective human embryonic kidney 293 cells
transiently transfected with TLR2-expressing plasmids and
the response was augmented by coexpression of TLR1 and
TLR2. Moreover, silencing of TLR2, myeloid differentiation
factor 88, and TNF receptor-associated factor 6 with specific
small interfering RNA significantly reduces the response
caused by OMP in proximal tubule cells. The OMP
stimulated CXCL1/KC secretion was also significantly
reduced by pre-incubating proximal tubule cells with a
specific p38 inhibitor. These results indicate that OMP
stimulates the production of CXCL1/KC to recruit poly-
morphonuclear neutrophils at the site of inflammation
through a TLR2-mediated pathway in renal tubule cells.
Thus, the leptospira OMP stimulated the phosphorylation of
three MAPK extracellular signal-regulated kinase, c-Jun
N-terminal kinase, and P38 and the increase of CXCL2/
MCP-1, CCL2/MIP-2, and CXCL1/KC was associated with
P38 pathway.48 Further inhibitor experiments showed that
the NF-kB pathway is associated with increased iNOS and
TNF-a in the proximal tubule cells. These experimental
results indicated that the two major pathways associated with
TLR2 signaling elaborated differential induction of different
cytokines or chemoattractants molecules responsible for early
inflammation. These results also implicate the crucial role of
innate immunity in leptospira-induced tubulointerstitial
nephritis (Figure 1).
By applying the same infection model to other organ
systems, a recent study has confirmed that microglial cells
respond to pathogenic but not non-pathogenic Leptospira
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infection with a time- and dose-dependent induction of
molecular signals including p38 phosphorylation and NF-kB
activation. This response is followed by the production of
soluble factors such as cytokines and nitric oxide. The
phenomenon is reproduced by leptospiral lipoproteins and,
to a lesser extent, by leptospiral-derived lipopolysaccharide.49
This study confirmed that a similar pathway of leptospira
cellular effects on different organ systems may exist and that
the leptospira OMP component has a relatively greater
importance than the leptospira lipopolysaccharide in eliciting
organ damages.
TLRS AND LEPTOSPIROSIS
Leptospiral outer membrane constituents were shown to
activate macrophages through TLR2 pathway.50 Leptospira
lipopolysaccharide constitutes the predominant signaling
component for macrophages through this pathway. Con-
versely, TLR4 is apparently not involved in cellular responses
to leptospira. Subsequently, TLR4 is known to be crucial for
protection from acute lethal infection and control of
leptospiral burden during sublethal chronic leptospira
infection in mice. Studies of a murine model, which directly
recapitulates severe human leptospirosis, suggest a critical
role of TLR4 gene or its associated components, in early
infection by leptospira.51 Intact TLR4 signaling contributes to
the control of the tissue burden of Leptospira in non-lethal
infection. Studies of TLR4-deficient mice have revealed
significantly higher numbers of leptospires, particularly in
the target organs such as the liver, and the lung for mediating
leptospiral disease and in kidney that both mediating and
transmitting leptospira. Macrophages from TLR4-deficient
mice secreted far-lower levels of cytokines than wild-type
macrophages in response to leptospira. The key finding was
that intact TLR4 function was critical for mouse survival and
for preventing jaundice, pulmonary hemorrhage, and death.
Thus, the TLR4 pathway may offer protection from severe
leptospirosis. Given the newly discovered role of TLR4 in
protection from lethal infection and the known role of TLR2
in the renal tubule in initiating inflammation, different
components of leptospira may activate different TLR path-
ways for a range of immune responses including inflamma-
tion, clearance, and protection. The responses may be diverse
in trend and in intensity in a number of organ systems
dependent on dissimilar TLRs.
In this context, experimental models using whole body
TLR-deficiency (knock-out model) or single organ TLR-
deficiency study (in vitro cell culture study) should be
interpreted with caution. Systemic or local effects on organ
damage may have dissimilar outcomes and may be complex
for interpreting the effect of TLRs.52 The effect could be
protective at local level of TLR-deficient status from stimuli;
on the contrary, the effect could be detrimental at systemic
stimulation. For instance, systemic infection in the TLR
deficiency model, in which first line defence mechanism is
disrupted, may be detrimental to the target organ rather than
protective, in contrast to study at local deficiency levels in the
cell culture system. Other examples are that in a sepsis model
and in a leptospirosis model, the outcome may differ when
systemic infection or local infection is induced. Thus, to
accurately interpret the role of TLR, one must realize the
threshold and level of pathogen–host immune responses to
determine and understand whether the protective or harmful
effect is due to innate TLR immunity. The experimental
results of these studies highlight the need for caution in the
assessment of disease paradigms.
LEPTOSPIROSIS AND RENAL FIBROSIS
The consequence of tubulointerstitial nephritis caused by
leptospiral infection is tubular atrophy and interstitial
fibrosis, if chronic leptospiral infection remain untreated.33
In canine and rat leptospirosis, the disease may undergo a
chronic course, leading to tubulointerstitial fibrosis and thus
chronic renal failure.33,53 Human biopsy studies have
demonstrated an association among infection of leptospiro-
sis, interstitial nephritis, and fibrosis.18 A recent report
further indicated that leptospirosis led to irreversible
tubulointerstitial fibrosis in a young male, who thus required
chronic hemodialysis.54
To elucidate the crucial association between leptospirosis
and renal fibrosis, the effect of OMP from pathogenic
leptospira on extracellular matrix accumulation has been
examined.55 Adding Leptospira santarosai serovar Shermani
OMP to proximal tubular cells, HK-2 cells, dose-dependently
led to an increase of type I and type IV collagens both at
mRNA and protein levels. The active transforming growth
factor-b1 (TGF-b1) secretion was increased twofolds follow-
ing an addition of leptospira OMP. Addition of anti-TGF-b1
neutralizing antibodies attenuated the increased production
of type I and type IV collagen, indicating the participation of
TGF-b1 in this process. These observations were further
confirmed by the increased nuclear translocation of Smad3
after administration of leptospira OMP, and overexpression
of the dominant-negative Smad3 prevented the leptospira
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Figure 1 | Differential induction of early inflammatory genes via
TLR2 Pathway by leptospira OMP in renal proximal tubule cells.
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OMP-induced increase of type I or type IV collagen
production. On the other hand, adding the OMP had no
effect on metalloproteinase activity. Therefore, the degrada-
tion pathway may not be altered. In summary, this study
clearly demonstrated the stimulatory effect of leptospira
OMP in enhancing extracellular matrix synthesis, which was
mediated by a TGF-b1/Smad-dependent pathway (Figure 2).
In this study, administering the OMP from Leptospira
santarosai serovar Shermani induced increased production of
type IV collagen, whereas addition of the OMP from a non-
pathogenic leptospira, Leptospira biflexa serovar Patoc, did
not alter production of this collagen. These findings were
compatible with our previous report demonstrating that
pathogenic leptospira, but not non-pathogenic leptospira, is
able to promote expression of iNOS, MCP-1, and TNF-a in
tubulointerstitial nephritis. In leptospirosis patients, kidney
biopsies have revealed increased expression of collagen I, IV,
TGF-b, and Smad in the tubulointerstitial area, which is in
vivo evidence of leptospirosis renal fibrosis (manuscript in
preparation). Overall, the most important finding of this
study is that pathogenic leptospira may induce renal fibrosis.
Whether the fibrosis pathway is directly or indirectly related
to activation of TLRs merits further study.
TLRS AND KIDNEY DISEASES
Available information indicates that renal TLRs may respond
to exogenous and endogenous ligands, and interact between
innate and adaptive immunity,56 thereby influencing kidney
function in health and disease. The renal TLRs are known to
be involved in pathogenesis of glomerulonephritis57–61 in
ischemia/reperfusion renal injury;62 sepsis-induced acute
renal failure;63 and transplant kidney rejection in favor of
TLR4 polymorphism.64,65 Experimental models have indi-
cated TLR deficiency may protect the renal injury.66,67
Therefore, TLRs may be involved in the initiation of diverse
renal diseases in response to different exogenous and
endogenous stimuli (Figure 3). On one hand, TLRs are the
first line of defence for innate immune protection. Con-
versely, TLRs may act as a ‘danger signal’ by triggering
inflammatory responses to stimuli when tailored immune
reactions cannot adequately resolve the inflammation. The
outcome may thus depend on a balanced or unbalanced
immune reaction leading to either health or disease. Based
on the study of isolated cell populations, in vitro or
in vivo studies of knockout animals involving genetic models
should cautiously interpret the final outcome and systemic
effects.
CONCLUSION AND PERSPECTIVE
The role of TLRs in initiation of kidney disease represents an
expanding and exciting area in the study of renal disease
initiation. In the study of kidney disease pathogenesis,
leptospirosis renal disease may serve to better understand
the initiation of micro-organism-related kidney diseases.
Recent research in leptospirosis renal disease suggests that
pathogenic leptospira initiates tubulointerstitial nephritis
through outer membrane components, which binds to
TLR2 in renal tubule cells. The binding of the receptor is
followed by activation of signaling pathways related
to inflammation that are induced differentially according to
different pathways. With more efficient approaches by
systems biology, other novel activation pathways can be
expected and understood in the future. More interestingly,
the induction of renal fibrosis by leptospira indicates the
possibility of pathogen-induced chronic renal diseases;
understanding the initiation of these diseases is therefore
critical. These findings offer a basis for understanding the
molecular mechanisms controlling the innate immune
response caused by leptospirosis in renal tubule cells that
will serve for future studies of the pathogenesis of micro-
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Figure 2 | Leptospira induces fibrosis pathway in the tubule cells
by activating TGF-b1/Smad pathway but not MAPK. The activation
results in increased production of extracellular matrix in the renal
tubule cells. These activations may lead to renal fibrosis in
leptospirosis patients.
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Figure 3 | The possible role of TLRs in initiation of kidney
diseases. TLRs may be involved in the initiation of diverse renal
diseases in response to exogenous and endogenous stimuli. On one
hand, TLRs are the first line of defence for innate immune protection.
Conversely, TLRs may act as a ‘danger signal’ by triggering
inflammatory responses to stimuli when tailored immune reactions
cannot adequately resolve the inflammation. The outcome may thus
depend on a balanced or unbalanced immune reaction leading to
either resolution or disease progression to renal fibrosis and
end-stage renal disease.
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organism-induced tubulointerstitial nephritis and initiation
of kidney diseases. In particular, TLRs may be important
mediators.
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